Paige

Overview

Paige is an AI-native digital pathology company headquartered at 33 Irving Place, New York, NY 10003[2][9]. The company develops artificial intelligence solutions for precision oncology and pathology analysis[1], selling applications to pathologists, clinical diagnostic laboratories, pharmaceutical and biotech firms, and research institutions[3]. Paige's clinical products include the Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, Paige PanCancer Detect, HER2Complete, the FullFocus whole-slide image viewer, and the FullFolio image management system[4]. The company publishes foundation models including Virchow, Virchow2, Virchow2G, Virchow2G-Mini, and PRISM, along with Paige Alba, a co-pilot application for pathologists[5]. Paige Prostate Detect was the first AI-based software application in pathology to receive FDA approval to aid in primary diagnosis of prostate cancer[6]. The company holds 13 CE-IVDD marks, 13 UKCA marks, and 3 FDA Breakthrough Designations[7]. Its PanCancer Suite was trained on over 1.5 million slides[8].

Headquarters at 33 Irving Place, New York, NY 10003 [2]

Paige publishes the foundation models Virchow, Virchow2, Virchow2G, Virchow2G-Mini and PRISM, plus Paige Alba, described as "a revolutionary new co-pilot designed to transform how pathologists work". [5]

Business address: 33 Irving Place, New York, NY 10003. [9]

Paige launched a system-wide AI application for the gastrointestinal tract on March 25, 2025, and on August 23, 2024 launched an AI tool that screens 505 genes for improved cancer diagnosis. [11]

Growth & traction

Paige states that "Paige Prostate Detect was the first AI-based software application in pathology to receive FDA approval to aid in the primary diagnosis of prostate cancer." [6]

Paige lists 13 CE-IVDD marks, 13 UKCA marks and 3 FDA Breakthrough Designations. [7]

Paige states its PanCancer Suite was "cumulatively trained on over 1.5 million slides". [8]

Paige's newsroom identifies Thomas Fuchs as a Paige cofounder in a July 10, 2024 Nvidia AI Podcast feature titled "Paige Cofounder Thomas Fuchs' Diagnosis on Improving Cancer Patient Outcomes With AI". [10]

Partnerships

Paige's newsroom carries an October 31, 2024 item on Microsoft unveiling new AI innovations for healthcare, and an August 1, 2024 item on Paige publishing open-source AI pathology models for cancer R&D. [12]